Home > Cashflow Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹343 Cr₹-814 Cr₹-164 Cr₹-145 Cr₹-152 Cr

What is the latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS is ₹343 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹343 Cr
Mar2025₹-814 Cr
Mar2024₹-164 Cr
Mar2023₹-145 Cr
Mar2022₹-152 Cr

How is Cash Flow from Financing Activities of EMCURE PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹343 Cr
Positive
Mar2025 ₹-814 Cr
Negative
Mar2024 ₹-164 Cr
Negative
Mar2023 ₹-145 Cr
Negative
Mar2022 ₹-152 Cr -

Compare Cash Flow from Financing Activities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹42,414.1 Cr -0.2% 20% 62.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 3.9% 7.8% 13% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 11.5% 20.6% 68% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1.1% 11.8% 14.9% Stock Analytics
CIPLA ₹114,478.0 Cr 1.1% 7.9% -6.3% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-0.2%

20%

62.9%

SENSEX

5.9%

13%

-1.9%


You may also like the below Video Courses